Whedon Samuel D, Lee Kwangwoon, Wang Zhipeng A, Zahn Emily, Lu Congcong, Yapa Abeywardana Maheeshi, Fairall Louise, Nam Eunju, DuBois-Coyne Sarah, De Ioannes Pablo, Sheng Xinlei, Andrei Adelina, Lundberg Emily, Jiang Jennifer, Armache Karim-Jean, Zhao Yingming, Schwabe John W R, Wu Mingxuan, Garcia Benjamin A, Cole Philip A
Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States.
Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
J Am Chem Soc. 2024 Dec 11;146(49):33914-33927. doi: 10.1021/jacs.4c12585. Epub 2024 Nov 25.
Reversible modification of the histone H3 N-terminal tail is critical in regulating the chromatin structure, gene expression, and cell states, while its dysregulation contributes to disease pathogenesis. Understanding the crosstalk between H3 tail modifications in nucleosomes constitutes a central challenge in epigenetics. Here, we describe an engineered sortase transpeptidase, cW11, that displays highly favorable properties for introducing scarless H3 tails onto nucleosomes. This approach significantly accelerates the production of both symmetrically and asymmetrically modified nucleosomes. We demonstrate the utility of asymmetrically modified nucleosomes produced in this way in dissecting the impact of multiple modifications on eraser enzyme processing and molecular recognition by a reader protein. Moreover, we show that cW11 sortase is very effective at cutting and tagging histone H3 tails from endogenous histones, facilitating multiplex "cut-and-paste" middle-down proteomics with tandem mass tags. This cut-and-paste proteomics approach permits the quantitative analysis of histone H3 modification crosstalk after treatment with different histone deacetylase inhibitors. We propose that these chemoenzymatic tail isolation and modification strategies made possible with cW11 sortase will broadly power epigenetic discovery and therapeutic development.
组蛋白H3 N端尾部的可逆修饰对于调节染色质结构、基因表达和细胞状态至关重要,而其失调会导致疾病发病机制。理解核小体中H3尾部修饰之间的相互作用是表观遗传学的核心挑战。在这里,我们描述了一种工程化的分选酶转肽酶cW11,它在将无痕H3尾部引入核小体方面具有非常有利的特性。这种方法显著加速了对称和不对称修饰核小体的产生。我们证明了以这种方式产生的不对称修饰核小体在剖析多种修饰对擦除酶加工和读取蛋白分子识别的影响方面的实用性。此外,我们表明cW11分选酶在从内源性组蛋白切割和标记组蛋白H3尾部方面非常有效,促进了使用串联质量标签的多重“切割粘贴”中向下蛋白质组学。这种切割粘贴蛋白质组学方法允许在使用不同组蛋白脱乙酰酶抑制剂处理后对组蛋白H3修饰相互作用进行定量分析。我们提出,这些利用cW11分选酶实现的化学酶促尾部分离和修饰策略将广泛推动表观遗传学发现和治疗发展。